PROACTIS: Doubling and Delivering

PROACTIS Plc | Published on 12/02/2018

PROACTIS’ interim trading statement provides the first opportunity to gauge performance since Perfect was consolidated. The overall picture looks healthy: revenue of £26.3m has more than doubled yoy and EBITDA of £8.5m is ahead our expectations (£8.0m). While customer activity is not quantified, it is described as strong, and the target of £5m in annualised synergies by the end of FY18 is confirmed. We believe PROACTIS can deliver £20m in EBITDA in FY18 and leave our forecasts unchanged.

Download full analysis

Login to access research or Register now

Register now or

I confirm that I understand that research from Progressive Equity Research Limited is not intended for retail investors, and should not be relied upon in any decision-making process. It is published for the benefit of institutional investors only, and for the use of professional advisors in the course of their work. I acknowledge that, if I am a private investor, I will take advice from a registered financial advisor or stockbroker before making any investment decisions. I understand that equity investments carry significant risk, and that past performance is no guarantee of future performance. I acknowledge that neither Progressive Equity Research Limited, nor any of its directors or officers, accepts any liability with regard to the contents of this research, and that nothing within the research on this site constitutes a recommendation or solicitation to buy or sell shares.

Recent Analysis

PROACTIS: Going for Scale

Published on 12/01/2018

PROACTIS: Setting the Stage

Published on 12/10/2017

PROACTIS: Powering on

Published on 13/09/2017

PROACTIS: Execution Engine

Published on 26/04/2017